MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517033397 A) filed by Myricx Pharma Limited; and Imperial College Innovations Limited, London, on April 4, for 'antibody drug conjugate comprising nmt inhibitor and its use.'
Inventor(s) include Carr Robin; Solari Roberto; Tate Edward William; Bell Andrew Simon; and Bonnert Roger.
The application for the patent was published on April 25, under issue no. 17/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker and related uses."
The patent application was internationally filed on Sept. 08, 2023, under International appl...